Trial Profile
Efficacy and Safety Study of Botulinum Toxin Type A for Moderate to Severe Crow's Feet Lines (RADIANT)
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 31 Oct 2014
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Facial wrinkles
- Focus Therapeutic Use
- Acronyms RADIANT
- Sponsors Revance Therapeutics
- 31 Oct 2014 New trial record